Alnylam Pharmaceuticals beats third-quarter earnings expectations
FROM THE WIRE · GURUFOCUS.COM
On November 17, 2026, Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) reported a remarkable earnings-per-share surprise of $14.01 for the third quarter, significantl
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishAn earnings beat can support the share price of a mid-sized biotech company.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Alnylam reported earnings per share of $14.01 for the third quarter.
- 02The earnings surprise was significant relative to expectations.
- 03The stock showed strong market performance.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets